330 related articles for article (PubMed ID: 19506387)
1. Graves' disease in childhood: advances in management with antithyroid drug therapy.
Kaguelidou F; Carel JC; Léger J
Horm Res; 2009; 71(6):310-7. PubMed ID: 19506387
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease in children.
Léger J
Endocr Dev; 2014; 26():171-82. PubMed ID: 25231452
[TBL] [Abstract][Full Text] [Related]
3. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
[TBL] [Abstract][Full Text] [Related]
4. Remission of Graves' hyperthyroidism treated with methimazole.
Bolaños F; González-Ortiz M; Durón H; Sánchez C
Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease in children.
Léger J; Kaguelidou F; Alberti C; Carel JC
Best Pract Res Clin Endocrinol Metab; 2014 Mar; 28(2):233-43. PubMed ID: 24629864
[TBL] [Abstract][Full Text] [Related]
6. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study.
Léger J; Gelwane G; Kaguelidou F; Benmerad M; Alberti C;
J Clin Endocrinol Metab; 2012 Jan; 97(1):110-9. PubMed ID: 22031519
[TBL] [Abstract][Full Text] [Related]
7. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
9. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
[TBL] [Abstract][Full Text] [Related]
10. [Long-term follow up after antithyroid drug treatment in Graves' disease].
Wille T; Müller B; Noth D; Bürgi U; Diem P
Praxis (Bern 1994); 2006 Jul; 95(29-30):1121-7. PubMed ID: 16916174
[TBL] [Abstract][Full Text] [Related]
11. Long-term monitoring of Graves’ disease in children and adolescents: a single-center experience.
Tunç S; Köprülü Ö; Ortaç H; Nalbantoğlu Ö; Dizdarer C; Demir K; Özkan B
Turk J Med Sci; 2019 Apr; 49(2):464-471. PubMed ID: 30862149
[TBL] [Abstract][Full Text] [Related]
12. [The surgical treatment of Graves' disease].
de Ruijter SH; van Dalen T; Muller AF
Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
[TBL] [Abstract][Full Text] [Related]
13. Graves' disease in children and adolescents: response to long-term treatment.
Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
[TBL] [Abstract][Full Text] [Related]
14. Hyperthyroidism in childhood: causes, when and how to treat.
Léger J; Carel JC
J Clin Res Pediatr Endocrinol; 2013; 5 Suppl 1(Suppl 1):50-6. PubMed ID: 23154161
[TBL] [Abstract][Full Text] [Related]
15. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
Glaser NS; Styne DM;
Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
[TBL] [Abstract][Full Text] [Related]
16. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
17. The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
Kim YA; Cho SW; Choi HS; Moon S; Moon JH; Kim KW; Park DJ; Yi KH; Park YJ; Cho BY
Thyroid; 2017 Apr; 27(4):491-496. PubMed ID: 28001121
[TBL] [Abstract][Full Text] [Related]
18. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
19. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment.
Kaguelidou F; Alberti C; Castanet M; Guitteny MA; Czernichow P; Léger J;
J Clin Endocrinol Metab; 2008 Oct; 93(10):3817-26. PubMed ID: 18628515
[TBL] [Abstract][Full Text] [Related]
20. Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal.
Orunesu E; Bagnasco M; Salmaso C; Altrinetti V; Bernasconi D; Del Monte P; Pesce G; Marugo M; Mela GS
Eur J Clin Invest; 2004 Mar; 34(3):210-7. PubMed ID: 15025680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
